These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8656987)

  • 1. Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA.
    Holman ER; van Rossum AC; Doesburg T; van der Wall EE; de Roos A; Visser CA
    Magn Reson Imaging; 1996; 14(1):21-9. PubMed ID: 8656987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra low-dose of gadobenate dimeglumine for late gadolinium enhancement (LGE) imaging in acute myocardial infarction: a feasibility study.
    Galea N; Francone M; Zaccagna F; Ciolina F; Cannata D; Algeri E; Agati L; Catalano C; Carbone I
    Eur J Radiol; 2014 Dec; 83(12):2151-2158. PubMed ID: 25293818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
    Doltra A; Skorin A; Hamdan A; Schnackenburg B; Gebker R; Klein C; Nagel E; Fleck E; Kelle S
    Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detectability of small liver metastases with gadolinium BOPTA.
    Runge VM; Lee C; Williams NM
    Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
    Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
    AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.
    Krombach GA; Hahnen C; Lodemann KP; Krämer N; Schoth F; Neizel M; Boeringer J; Günther RW; Kelm M; Kühl H
    Eur Radiol; 2009 Sep; 19(9):2136-46. PubMed ID: 19373470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intraaxial enhancing brain tumors on magnetic resonance imaging: intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for visualization and assessment, and implications for surgical intervention.
    Kuhn MJ; Picozzi P; Maldjian JA; Schmalfuss IM; Maravilla KR; Bowen BC; Wippold FJ; Runge VM; Knopp MV; Wolansky LJ; Gustafsson L; Essig M; Anzalone N
    J Neurosurg; 2007 Apr; 106(4):557-66. PubMed ID: 17432704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of a diluted high-relaxivity gadolinium-based intra-articular contrast agent for magnetic resonance arthrography: an in-vitro study.
    Messina C; Albano D; Orlandi D; Chianca V; Corazza A; Ferrari F; Gitto S; Sconfienza LM
    BMC Med Imaging; 2019 Oct; 19(1):83. PubMed ID: 31653206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
    Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
    Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
    Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus GD-DTPA on inversion recovery EPI.
    Wendland MF; Saeed M; Lauerma K; Derugin N; Mintorovitch J; Cavagna FM; Higgins CB
    Magn Reson Med; 1997 Mar; 37(3):448-56. PubMed ID: 9055236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
    Grazioli L; Morana G; Caudana R; Benetti A; Portolani N; Talamini G; Colombari R; Pirovano G; Kirchin MA; Spinazzi A
    Invest Radiol; 2000 Jan; 35(1):25-34. PubMed ID: 10639033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
    Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
    Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses.
    Schima W; Saini S; Petersein J; Weissleder R; Harisinghani M; Mayo-Smith W; Hahn PF
    J Magn Reson Imaging; 1999 Jul; 10(1):80-3. PubMed ID: 10398981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C; Bazzocchi M; Mortele KJ; Zuiani C; Londero V; Como G; Zanardi R; Ros PR
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.